In view of the role of fusion protein TMPRSS2-ERG in prostate cancer and to expand our previous studies on the transcriptional regulation of the IGF1R gene, we examined the hypothesis that the IGF1R gene constitutes a novel downstream target for the TMPRSS2-ERG prostate-specific chimera. The gene discussed is ERG; the disease is prostate carcinoma.